Sílvia Pascual

629 total citations
18 papers, 372 citations indexed

About

Sílvia Pascual is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sílvia Pascual has authored 18 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Sílvia Pascual's work include Asthma and respiratory diseases (6 papers), Respiratory and Cough-Related Research (5 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Sílvia Pascual is often cited by papers focused on Asthma and respiratory diseases (6 papers), Respiratory and Cough-Related Research (5 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Sílvia Pascual collaborates with scholars based in Spain, United States and Austria. Sílvia Pascual's co-authors include Isabel Urrutia, Aitor Ballaz, Rosa Díez, Pedro Pablo España, José M. Quintana, Amaia Bilbao, Alberto Capelastegui, Mikel Egurrola, Cristóbal Esteban and Josep M. Jansat and has published in prestigious journals such as PLoS ONE, Brain and Neurology.

In The Last Decade

Sílvia Pascual

18 papers receiving 358 citations

Peers

Countries citing papers authored by Sílvia Pascual

Since Specialization

Citations

This map shows the geographic impact of Sílvia Pascual's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sílvia Pascual with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sílvia Pascual more than expected).

Fields of papers citing papers by Sílvia Pascual

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sílvia Pascual. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sílvia Pascual. The network helps show where Sílvia Pascual may publish in the future.

Co-authorship network of co-authors of Sílvia Pascual

This figure shows the co-authorship network connecting the top 25 collaborators of Sílvia Pascual. A scholar is included among the top collaborators of Sílvia Pascual based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sílvia Pascual. Sílvia Pascual is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Clinical pharmacokinetics of leriglitazone and a translational approach using PBPK modeling to guide the selection of the starting dose in children 2024 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Laura Rodríguez‐Pascau, (unknown), (unknown), Sílvia Pascual, Sonia Poli, (unknown), (unknown), Alice Ke, Andreas Lindauer, Marc Martinell, Pilar Pizcueta	2
2	Leriglitazone halts disease progression in adult patients with early cerebral adrenoleukodystrophy 2024 ·Brain ·(unknown), Isabelle Weinhofer, (unknown), Magali Barbier, (unknown), (unknown), Boris Chaumette, (unknown), Ali Fatemi, Sílvia Pascual, Marc Martinell, Johannes Berger, Vincent Perlbarg, Damien Galanaud, Fanny Mochel	5
3	Clinical burden related to oral corticosteroid treatment of severe asthma in Spain: LEVANTE study 2022 ·Journal of Asthma ·Xavier Muñoz, Javier Domínguez‐Ortega, Sílvia Pascual, Carlos Cabrera López, (unknown), Javier Nuevo, (unknown)	2
4	Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia 2022 ·Neurology Genetics ·Massimo Pandolfo, Kathrin Reetz, Alejandra Darling, Francisco Javier Rodríguez de Rivera Garrido, Pierre‐Gilles Henry, James M. Joers, Christophe Lenglet, Isaac Adanyeguh, Dinesh K. Deelchand, Fanny Mochel, Françoise Pousset, Sílvia Pascual, (unknown), (unknown), (unknown), (unknown), (unknown), Marc Martinell, (unknown), Alexandra Dürr	17
5	The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy 2021 ·Science Translational Medicine ·Laura Rodríguez‐Pascau, Anna Vilalta, (unknown), (unknown), Sonja Forss‐Petter, Isabelle Weinhofer, Jan Bauer, Stephan Kemp, (unknown), Sílvia Pascual, (unknown), Patricia L. Musolino, Johannes Berger, Marc Martinell, Pilar Pizcueta	27
6	Association of the CFTR gene with asthma and airway mucus hypersecretion 2021 ·PLoS ONE ·Astrid Crespo‐Lessmann, Sara Bernal, Elisabeth del Río, (unknown), Carlos Martínez‐Rivera, (unknown), Abel Pallarés-Sanmartín, Sílvia Pascual, Juan Luis García‐Rivero, Alicia Padilla‐Galo, Elena Curto, Carolina Cisneros, José Serrano, Montserrat Baiget, Vicente Plaza, (unknown)	10
7	A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effects on Biomarkers of MIN-102 (Leriglitazone) (4149) 2020 ·Neurology ·(unknown), (unknown), Sílvia Pascual, (unknown), Pilar Pizcueta, Marc Martinell, (unknown), Jeroen van de Wetering de Rooij	3
8	Predicting 1-year mortality after hospitalization for community-acquired pneumonia 2018 ·PLoS ONE ·Ane Uranga, José M. Quintana, Urko Aguirre, (unknown), Rosa Díez, Sílvia Pascual, Aitor Ballaz, Pedro Pablo España	19
9	Accreditation of specialized asthma units for adults in Spain: an applicable experience for the management of difficult-to-control asthma 2017 ·Journal of Asthma and Allergy ·Carolina Cisneros, (unknown), (unknown), Carlos Melero Moreno, Alicia Padilla‐Galo, Sílvia Pascual, (unknown), (unknown)	14
10	Asthma control and concordance of opinions between patients and pulmonologists 2013 ·Journal of Asthma ·Isabel Urrutia, Vicente Plaza, Sílvia Pascual, Carolina Cisneros, Luis Manuel Entrenas Costa, (unknown), Fernando Caballero	17
11	Impact of Anxiety and Depression on Disease Control and Quality of Life in Asthma Patients 2012 ·Journal of Asthma ·Isabel Urrutia, Urko Aguirre, Sílvia Pascual, Cristóbal Esteban, Aitor Ballaz, (unknown), (unknown)	49
12	Pharmacokinetics and safety of aclidinium bromide in younger and elderly patients with chronic obstructive pulmonary disease 2012 ·International Journal of Clinical Pharmacology and Therapeutics ·Stephan de la Motte, Jutta Beier, Karin Schmid‐Zalaudek, Sílvia Pascual, Josep M. Jansat, Esther García Gil	20
13	Prevalence of Silicosis in a Marble Factory after Exposure to Quartz Conglomerates 2011 ·Archivos de Bronconeumología ·Sílvia Pascual, Isabel Urrutia, Aitor Ballaz, (unknown), (unknown), (unknown)	22
14	Prevalencia de silicosis en una marmolería tras la exposición a conglomerados de cuarzo 2010 ·Archivos de Bronconeumología ·Sílvia Pascual, Isabel Urrutia, Aitor Ballaz, (unknown), (unknown), (unknown)	26
15	Pharmacokinetics and safety of aclidinium bromide, a muscarinic antagonist, in adults with normal or impaired renal function: A phase I, open-label, single-dose clinical trial 2010 ·Clinical Therapeutics ·Karin Schmid‐Zalaudek, Sílvia Pascual, Esther García Gil, Stephan Ortiz, Josep M. Jansat	27
16	Predictors of Short-term Rehospitalization Following Discharge of Patients Hospitalized With Community-Acquired Pneumonia 2009 ·CHEST Journal ·Alberto Capelastegui, Pedro Pablo España, José M. Quintana, Amaia Bilbao, Rosa Díez, Sílvia Pascual, (unknown), Mikel Egurrola	78
17	Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia 2009 ·Journal of Infection ·Pedro Pablo España, Alberto Capelastegui, José M. Quintana, Amaia Bilbao, Rosa Díez, Sílvia Pascual, Cristóbal Esteban, Rafael Zalacaín, Rosario Menéndez, Antoní Torres	27
18	Los semejantes y los otros: la sepultura múltiple simultánea de Villayerno-Morquillas, Burgos: Nota preliminar 1997 ·UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) ·(unknown), Sílvia Pascual, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact